Literature DB >> 25550985

Association between plasma homocysteine status and hypothyroidism: a meta-analysis.

Yande Zhou1, Yufang Chen1, Xueqin Cao1, Chunfeng Liu2, Ying Xie1.   

Abstract

PURPOSE: To figure out plasma homocysteine (Hcy) status in patients with subclinical hypothyroidism (SH) and overt hypothyroidism (OH) compared with healthy subjects, and the effect of levothyroxine (L-T4) on plasma homocysteine status in patients with hypothyroidism.
METHODS: PubMed Web of Science, and The Cochrane Library were used to identify eligible studies. The Newcastle-Ottawa Quality Assessment Scale was used to assess the quality of selected studies. All analyses were performed using the STATA, version 12 software.
RESULTS: Our meta-analysis indicated that plasma Hcy concentrations elevated in OH patients without L-T4 treatment compared with healthy subjects. However, this elevation was not observed in the comparison between patients withSH without L-T4 treatment and healthy subjects. Moreover, plasma Hcy levels were found to be higher in patients with OH without L-T4 treatment than in patients with SH without L-T4 treatment. Finally, plasma Hcy concentrations decreased after L-T4 treatment in patients with SH or OH.
CONCLUSIONS: Plasma Hcy status is associated with the severity of hypothyroidism and L-T4 treatment is helpful for patients with hypothyroidism to reduce the plasma Hcy levels.

Entities:  

Keywords:  Homocysteine; levothyroxine; meta-analysis; overt hypothyroidism; subclinical hypothyroidism

Year:  2014        PMID: 25550985      PMCID: PMC4276243     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  49 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

2.  Lifestyle factors and plasma homocysteine concentrations in a general population sample.

Authors:  A de Bree ; W M Verschuren; H J Blom; D Kromhout
Journal:  Am J Epidemiol       Date:  2001-07-15       Impact factor: 4.897

3.  Effect of treatment of hypothyroidism on the plasma concentrations of neuroactive steroids and homocysteine.

Authors:  M Bicíková; J Tallová; M Hill; A Vañuga; Z Putz; J Tomandl
Journal:  Clin Chem Lab Med       Date:  2001-08       Impact factor: 3.694

4.  Emerging cardiovascular risk factors in subclinical hypothyroidism: lack of change after restoration of euthyroidism.

Authors:  A Pérez; J M Cubero; N Sucunza; E Ortega; R Arcelús; J Rodriguez-Espinosa; J Ordoñez-Llanos; F Blanco-Vaca
Journal:  Metabolism       Date:  2004-11       Impact factor: 8.694

5.  Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.

Authors:  S S Soedamah-Muthu; N Chaturvedi; T Teerlink; B Idzior-Walus; J H Fuller; C D A Stehouwer
Journal:  J Intern Med       Date:  2005-11       Impact factor: 8.989

6.  The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.

Authors:  Omer Ozcan; Erdinc Cakir; Halil Yaman; Emin Ozgur Akgul; Kivilcim Erturk; Zeynel Beyhan; Cumhur Bilgi; Mehmet Kemal Erbil
Journal:  Clin Endocrinol (Oxf)       Date:  2005-08       Impact factor: 3.478

7.  Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism.

Authors:  M Adrees; J Gibney; N El-Saeity; G Boran
Journal:  Clin Endocrinol (Oxf)       Date:  2008-12-15       Impact factor: 3.478

8.  Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism.

Authors:  M Emre Atabek; Ozgur Pirgon; Ibrahim Erkul
Journal:  J Pediatr Endocrinol Metab       Date:  2003-12       Impact factor: 1.634

9.  Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation.

Authors:  Melvin R Hayden; Suresh C Tyagi
Journal:  Nutr J       Date:  2004-05-10       Impact factor: 3.271

10.  Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism.

Authors:  Serpil Turhan; Sevilay Sezer; Gonul Erden; Ali Guctekin; Fatma Ucar; Zeynep Ginis; Ozlem Ozturk; Sezin Bingol
Journal:  Ann Saudi Med       Date:  2008 Mar-Apr       Impact factor: 1.526

View more
  15 in total

1.  Meta-analytic evidence for increased low-grade systemic inflammation and oxidative stress in hypothyroid patients. Can levothyroxine replacement therapy mitigate the burden?

Authors:  Mariana L Tellechea
Journal:  Endocrine       Date:  2020-09-02       Impact factor: 3.633

2.  Hyperhomocysteinemia in acute iatrogenic hypothyroidism: the relevance of thyroid autoimmunity.

Authors:  F Cicone; M G Santaguida; G My; G Mancuso; A Papa; R Persechino; C Virili; N Brusca; A Tofani; F Scopinaro; M Centanni
Journal:  J Endocrinol Invest       Date:  2017-12-29       Impact factor: 4.256

3.  Thyroid and Cardiovascular Disease: Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Thyroid       Date:  2019-05-13       Impact factor: 6.568

4.  Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.

Authors:  Anne R Cappola; Akshay S Desai; Marco Medici; Lawton S Cooper; Debra Egan; George Sopko; Glenn I Fishman; Steven Goldman; David S Cooper; Samia Mora; Peter J Kudenchuk; Anthony N Hollenberg; Cheryl L McDonald; Paul W Ladenson
Journal:  Circulation       Date:  2019-05-13       Impact factor: 29.690

Review 5.  Relationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.

Authors:  Jian Song; Song Chen; Xiaoting Liu; Hongtao Duan; Jiahui Kong; Zedong Li
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

6.  Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects.

Authors:  Shasha Luo; Chao Shi; Furu Wang; Zhifeng Wu
Journal:  Int J Environ Res Public Health       Date:  2016-11-15       Impact factor: 3.390

7.  Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.

Authors:  Jee Hyun An; Kee-Ho Song; Dong-Lim Kim; Suk Kyeong Kim
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

Review 8.  The metabolism and significance of homocysteine in nutrition and health.

Authors:  Avinash Kumar; Henry A Palfrey; Rashmi Pathak; Philip J Kadowitz; Thomas W Gettys; Subramanyam N Murthy
Journal:  Nutr Metab (Lond)       Date:  2017-12-22       Impact factor: 4.169

9.  A Meta-Analysis of Association between Methylenetetrahydrofolate Reductase Gene (MTHFR) 677C/T Polymorphism and Diabetic Retinopathy.

Authors:  Shasha Luo; Furu Wang; Chao Shi; Zhifeng Wu
Journal:  Int J Environ Res Public Health       Date:  2016-08-10       Impact factor: 3.390

10.  Headache Disorders May Be a Risk Factor for the Development of New Onset Hypothyroidism.

Authors:  Andrew T Martin; Susan M Pinney; Changchun Xie; Robert L Herrick; Yun Bai; Jeanette Buckholz; Vincent T Martin
Journal:  Headache       Date:  2016-09-27       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.